Members |
targetComponentId |
humant Cw9(w3)-leukocytantigen |
Human leucocyte antigen Cw9(w3) |
Antigen test |
Antigen test (procedure) |
Antigen test |
Antigen test (procedure) |
antigen från Lyme borreliosis |
Borrelia burgdorferi antigen |
Antigen-free surroundings |
Antigen-free surroundings |
Antihaemophilic factor transfusion |
Antihaemophilic factor transfusion |
Antihelminth drug prophylaxis |
Administration of prophylactic antihelminth (procedure) |
medel mot hemorrojder |
Haemorrhoid preparation |
Antihistamines |
Product containing histamine receptor antagonist (product) |
överdos av antihypertonimedel, med oklar avsikt |
Antihypertensive overdose |
Antihypertensive therapy |
Antihypertensive therapy |
Antihypertensive therapy |
Antihypertensive therapy |
Antilean piculet |
Nesoctites micromegas (organism) |
överdos av läkemedel mot lepra, med oklar avsikt |
Antileprotic drug overdose |
förgiftning orsakad av läkemedel mot lepra, med oklar avsikt |
Antileprotic drug poisoning |
Antileprotic drug reaction |
Antileprotic drug adverse reaction |
Antileprotic drug reaction |
Antileprotic drug adverse reaction |
Antimalarial drugs |
Antimalarial agent |
Antimicrobial activity |
Antimicrobial activity (finding) |
Antimicrobial activity |
Antimicrobial activity (finding) |
Antimicrobial drug level |
Antibiotic measurement |
Antimicrobial drug level |
Antibiotic measurement |
Antimicrobial drug level |
Antibiotic measurement |
Antimicrobial susceptibility test |
Antimicrobial susceptibility test |
Antimicrobial susceptibility test |
Antimicrobial susceptibility test |
mineralkortikoidantagonist |
Aldosterone receptor antagonist |
Antimitochondrial autoantibod. (& level) |
Antibody to mitochondria measurement |
antimitotiskt medel |
Product containing mitotic inhibitor (product) |
antimitotiskt medel |
Mitotic inhibitor |
överdos av antimonförening, med oklar avsikt |
Antimony compound overdose |
Antimony drug compound |
Product containing antimony (medicinal product) |
Antimony sodium stibogluconate |
Sodium stibogluconate (substance) |
Antimuscarinic |
Product containing muscarinic receptor antagonist (product) |
Antimycobacterial antibiotic poisoning |
Poisoning by antimycobacterial drug |
cytostatikaregim |
Antineoplastic chemotherapy regimen (regime/therapy) |
Antineutrophil cytoplasmic antibody positive |
Antineutrophil cytoplasmic antibody positive |
Antiphobic therapy |
Antiphobic therapy |
Antiphospholipid syndrome |
Antiphospholipid syndrome |
medel mot protozoer |
Antiprotozoal agent |
Antipsychotic drug |
Medicinal product acting as antipsychotic agent (product) |
Antipyretic poisoning, NEC |
Antipyretic poisoning, NEC |
Antipyretic poisoning, NEC |
Antipyretic poisoning, NEC |
förgiftning orsakad av antireumatiskt läkemedel, med oklar avsikt |
Poisoning by antirheumatic |
medel mot seborré |
Medicinal product acting as antiseborrheic agent (product) |
överdos av spasmolytika, med oklar avsikt |
Antispasmodic overdose |
förgiftning orsakad av spasmolytikum, med oklar avsikt |
Antispasmodic poisoning |
Antispasmodics and other drugs altering gut motility |
Medicinal product acting as antispasmodic agent (product) |
Antistreptolysin O antibody titre |
Antistreptolysin O titer |
mätning av antikroppstiter avseende streptolysin O |
Antistreptolysin O titer |
Antithrombin II |
Antithrombin III |
Antithrombin III level |
Antithrombin III assay |
Antithrombin III preparation |
Antithrombin III |
Antithrombin III product |
Product containing antithrombin III (medicinal product) |
Antituberculous drugs |
Medicinal product acting as antitubercular agent (product) |
Antivaricose drug |
Antivaricose agent (substance) |
Antiviral preparations |
Substance with antiviral mechanism of action (substance) |
Antrochoanal polyp |
Choanal polyp |
Antrochoanal polyp |
Choanal polyp |
Anuria |
Anuria |
Anxiety about blushing |
Anxiety about blushing |
Anxiety management training |
Anxiety management training |
Anxiety management training |
Anxiety management training |
Anxiolytic agent |
Anxiolytic agent |
Anxiolytics |
Anxiolytic agent |
Anxious cognitions |
Worried |
Anxious cognitions |
Worried |
Anxious personality disorder |
Anxious personality disorder |
Anxiousness (& symptom) |
Anxiety |
Aorta operations |
Operation on aorta (procedure) |
Aorta palpable |
Aorta palpable |
Aortic aneurysm |
Aortic aneurysm |
Aortic aneurysm NOS |
Aortic aneurysm NOS |
Aortic aneurysm NOS |
Aortic aneurysm NOS |
Aortic aneurysm screening |
Aortic aneurysm screening |
Aortic arch anomalies |
Congenital anomaly of aortic arch |
Aortic atherosclerosis |
Atherosclerosis of aorta |
Aortic coarctation |
Coarctation of aorta |
Aortic incompetence, non-rheumatic |
Aortic incompetence, non-rheumatic |
Aortic root arteriogram |
Angiography of aortic root (procedure) |
Aortic septal defect |
Aortopulmonary window |
Aortic stenosis |
Aortic valve stenosis |
Aortic stenosis, non-rheumatic |
Aortic stenosis, non-rheumatic |
aortaklaffringhypoplasi |
Congenital hypoplasia of annulus fibrosus of aorta (disorder) |
Aortic valve ventriculoarterial gradient |
Aortic valve ventriculoarterial gradient |
Aortic valve ventriculoarterial gradient |
Aortic valve ventriculoarterial gradient |
aortokoronar bypassoperation |
Aortocoronary artery bypass graft |
Aortopulmonary septal anomaly |
Aortopulmonary window |
Aortopulmonary window |
Aortopulmonary window |
Aotus |
Genus Aotus (organism) |
Apathy |
Indifference |
Apatite-associated destructive arthritis |
Apatite-associated destructive arthritis |
Apazone product |
Product containing azapropazone (medicinal product) |
Aperts syndrom |
Acrocephalosyndactyly type I |
Apgar at 1 minute |
Apgar at 1 minute |
Apgar at 1 minute = 0 |
Apgar at 1 minute = 0 |
Apgar at 1 minute = 1 |
Apgar at 1 minute = 1 |
Apgar at 1 minute = 10 |
Apgar at 1 minute = 10 |
Apgar at 1 minute = 2 |
Apgar at 1 minute = 2 |
Apgar at 1 minute = 3 |
Apgar at 1 minute = 3 |
Apgar at 1 minute = 4 |
Apgar at 1 minute = 4 (finding) |
Apgar at 1 minute = 5 |
Apgar at 1 minute = 5 |